262 related articles for article (PubMed ID: 27343192)
1. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
[TBL] [Abstract][Full Text] [Related]
2. Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
Komissarov AA; Florova G; Azghani A; Karandashova S; Kurdowska AK; Idell S
Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L682-92. PubMed ID: 23997178
[TBL] [Abstract][Full Text] [Related]
3. Single-chain urokinase in empyema induced by Pasturella multocida.
Idell S; Jun Na M; Liao H; Gazar AE; Drake W; Lane KB; Koenig K; Komissarov A; Tucker T; Light RW
Exp Lung Res; 2009 Oct; 35(8):665-81. PubMed ID: 19895321
[TBL] [Abstract][Full Text] [Related]
4. The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.
Komissarov AA; Florova G; Azghani AO; Buchanan A; Bradley WM; Schaefer C; Koenig K; Idell S
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L562-72. PubMed ID: 26163512
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
[TBL] [Abstract][Full Text] [Related]
6. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.
Florova G; Azghani A; Karandashova S; Schaefer C; Koenig K; Stewart-Evans K; Declerck PJ; Idell S; Komissarov AA
Am J Respir Cell Mol Biol; 2015 Apr; 52(4):429-37. PubMed ID: 25140386
[TBL] [Abstract][Full Text] [Related]
7. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
[TBL] [Abstract][Full Text] [Related]
8. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
Florova G; Azghani AO; Karandashova S; Schaefer C; Yarovoi SV; Declerck PJ; Cines DB; Idell S; Komissarov AA
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L54-L68. PubMed ID: 28860148
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema.
Beckert L; Brockway B; Simpson G; Southcott AM; Lee YCG; Rahman N; Light RW; Shoemaker S; Gillies J; Komissarov AA; Florova G; Ochran T; Bradley W; Ndetan H; Singh KP; Sarva K; Idell S
JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30998508
[TBL] [Abstract][Full Text] [Related]
10. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
12. Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema.
Florova G; Girard RA; Azghani AO; Sarva K; Buchanan A; Karandashova S; DeVera CJ; Morris D; Chamiso M; Koenig K; Cines DB; Idell S; Komissarov AA
Physiol Rep; 2021 May; 9(9):e14861. PubMed ID: 33991465
[TBL] [Abstract][Full Text] [Related]
13. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2004; (2):CD002312. PubMed ID: 15106174
[TBL] [Abstract][Full Text] [Related]
14. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
15. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
Iakhiaev AV; Nalian A; Koenig K; Idell S
Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
[TBL] [Abstract][Full Text] [Related]
16. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
Kemper P; Köhler D
Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
Karandashova S; Florova G; Azghani AO; Komissarov AA; Koenig K; Tucker TA; Allen TC; Stewart K; Tvinnereim A; Idell S
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):44-52. PubMed ID: 23002099
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model.
Zhu Z; Hawthorne ML; Guo Y; Drake W; Bilaceroglu S; Misra HL; Light RW
Chest; 2006 Jun; 129(6):1577-83. PubMed ID: 16778278
[TBL] [Abstract][Full Text] [Related]
19. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema.
Cameron R
Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]